Health
Johnson & Johnson COVID-19 vaccine linked to potentially paralysing Guillain-Barré syndrome – 7NEWS.com.au
Just weeks ago, the TGA granted the vaccine provisional approval for use in Australia.
There are fears some recipients of Johnson & Johnsons coronavirus vaccine face an increased risk of a rare neurological complication known as Guillain-Barre syndrome (GBS) after an increase in reports of the sometimes paralysing condition.
The US Food and…
Continue Reading
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General19 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor
-
Noosa News17 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station